Jefferies Financial Group Inc. Has $784,000 Stake in Axon Enterprise, Inc $AXON

Jefferies Financial Group Inc. trimmed its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 53.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,381 shares of the biotechnology company’s stock after selling 1,582 shares during the period. Jefferies Financial Group Inc.’s holdings in Axon Enterprise were worth $784,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. NEOS Investment Management LLC grew its stake in Axon Enterprise by 82.7% during the third quarter. NEOS Investment Management LLC now owns 25,369 shares of the biotechnology company’s stock worth $18,206,000 after buying an additional 11,482 shares in the last quarter. Vanguard Group Inc. grew its stake in Axon Enterprise by 4.2% during the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after buying an additional 376,904 shares in the last quarter. Legal & General Group Plc grew its stake in Axon Enterprise by 3.1% during the third quarter. Legal & General Group Plc now owns 421,114 shares of the biotechnology company’s stock worth $302,208,000 after buying an additional 12,736 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in Axon Enterprise by 93.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock worth $13,270,000 after buying an additional 11,262 shares in the last quarter. Finally, BIT Capital GmbH boosted its stake in shares of Axon Enterprise by 75.6% in the 3rd quarter. BIT Capital GmbH now owns 3,535 shares of the biotechnology company’s stock valued at $2,537,000 after purchasing an additional 1,522 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have recently weighed in on AXON. UBS Group reduced their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. JPMorgan Chase & Co. raised their price target on shares of Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. TD Cowen reduced their price target on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. Morgan Stanley set a $600.00 price target on shares of Axon Enterprise in a research note on Thursday, May 7th. Finally, Piper Sandler reduced their price target on shares of Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating on the stock in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $712.75.

Insider Buying and Selling at Axon Enterprise

In related news, Director Erika Nardini sold 198 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the transaction, the director owned 1,946 shares in the company, valued at $985,804.68. This trade represents a 9.24% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeri Williams sold 157 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares of the company’s stock, valued at approximately $567,910. This trade represents a 11.93% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 3,855 shares of company stock worth $1,837,408 in the last 90 days. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Trading Up 2.1%

AXON opened at $448.72 on Friday. The company’s 50 day moving average is $407.53 and its 200-day moving average is $494.65. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $885.91. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The company has a market cap of $36.17 billion, a P/E ratio of 180.21, a PEG ratio of 7.99 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm’s quarterly revenue was up 33.7% on a year-over-year basis. During the same quarter last year, the business earned $1.47 EPS. Equities research analysts predict that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.